Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $14.06 Analyst target: $50.12 Upside: 256.47%
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is headquartered in Waltham, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.